Amiodarone HCL 200 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F57KL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,239
Award facts
- Contract value 100% obligated
- $12,239.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Amiodarone HCl 200 mg tablets (60-count) with a ceiling value of $12,239.08 and an ultimate completion date of January 16, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. The contract is executed under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the comprehensive vehicle for pharmaceutical supply across military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a broad range of medications and medical supplies to military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains, from specialty medications and vaccines to generic drugs and medical devices. This delivery order for Amiodarone HCl—a cardiac antiarrhythmic medication—supports the Defense Logistics Agency's mission to maintain adequate pharmaceutical inventories for military treatment facilities and defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F57KL?
SPE2DR26F57KL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F57KL worth?
The government has obligated $12,239 on SPE2DR26F57KL.
Is contract SPE2DR26F57KL an order under another contract?
Yes. SPE2DR26F57KL is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57KL competed?
The extent of competition for SPE2DR26F57KL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award